Barbara K. Finck

Chief Medical Officer, Coherus BioSciences (United States).

Companies

Forte Biosciences, Inc.Board member Mar 18, 2022 to now¹
Comera Life Sciences Holdings, Inc.Board member May 20, 2022 to Feb 14, 2023²
Coherus BioSciences (United States)Chief Medical Officer Nov 6, 2014 to Sep 12, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Comera Life Sciences Holdings, Inc.23,033 shares⁴Jan 4, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 4, 2023Bought 6,756 shares at $1.23 of Comera Life Sciences Holdings, Inc.⁴
Jan 4, 2023Granted 6,756 shares at $1.23 of Comera Life Sciences Holdings, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARForte Biosciences, Inc., Board member
2
SEC EDGARComera Life Sciences Holdings, Inc., Board member
3
SEC EDGARCoherus BioSciences (United States), Chief Medical Officer
4
SEC EDGARComera Life Sciences Holdings, Inc. shares after the filing of Jan 4, 2023
5
SEC EDGARForm 4 filed Jan 6, 2023